SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007953
Filing Date
2024-05-13
Accepted
2024-05-13 16:01:43
Documents
67
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20240331x10q.htm   iXBRL 10-Q 1359188
2 EX-10.1 vygr-20240331xex10d1.htm EX-10.1 47301
3 EX-10.4 vygr-20240331xex10d4.htm EX-10.4 60444
4 EX-31.1 vygr-20240331xex31d1.htm EX-31.1 12998
5 EX-31.2 vygr-20240331xex31d2.htm EX-31.2 13737
6 EX-32.1 vygr-20240331xex32d1.htm EX-32.1 10719
7 GRAPHIC vygr-20240331x10q006.jpg GRAPHIC 89047
  Complete submission text file 0001558370-24-007953.txt   6500239

Data Files

Seq Description Document Type Size
8 EX-101.SCH vygr-20240331.xsd EX-101.SCH 42043
9 EX-101.CAL vygr-20240331_cal.xml EX-101.CAL 49127
10 EX-101.DEF vygr-20240331_def.xml EX-101.DEF 186588
11 EX-101.LAB vygr-20240331_lab.xml EX-101.LAB 381278
12 EX-101.PRE vygr-20240331_pre.xml EX-101.PRE 301048
71 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20240331x10q_htm.xml XML 1055219
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 24938872
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)